Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Lineage Cell Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- −17 vs. Q2 2025
- Shares held
- 87.9M
- −9.85M (−10.1%) vs. Q2 2025
- Total value
- $148.6M
- +$60.2M (+68.2%) vs. Q2 2025
- New holders
- 17
- 23 more added
- Sold out
- 34
- 33 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gsa Capital Partners LLP | 670,856 | $1.13M | 0.09% | −226,755−25.3% | Reduced |
| State Street Corp | 955,622 | $1.62M | 0.00% | +106,100+12.5% | Added |
| Morgan Stanley | 1,006,451 | $1.70M | 0.00% | +168,988+20.2% | Added |
| Dauntless Investment Group, LLC | 1,614,100 | $2.73M | 7.16% | +408,170+33.8% | Added |
| Renaissance Technologies LLC | 1,905,633 | $3.22M | 0.00% | −66,702−3.4% | Reduced |
| BlackRock, Inc. | 2,230,756 | $3.77M | 0.00% | −29,992−1.3% | Reduced |
| Geode Capital Management, LLC | 2,419,766 | $4.09M | 0.00% | −11,853−0.5% | Reduced |
| Millennium Management LLC | 2,680,003 | $4.53M | 0.00% | +79,426+3.1% | Added |
| Comerica Bank | 4,600,000 | $7.77M | 0.03% | 00.0% | Unchanged |
| Raffles Associates LP | 5,387,788 | $9.11M | 8.48% | −4,300−0.1% | Reduced |
| Vanguard Group Inc | 9,006,930 | $15.2M | 0.00% | +524,057+6.2% | Added |
| Broadwood Capital Inc | 49,560,992 | $83.8M | 5.07% | 00.0% | Unchanged |
| Defender Capital, LLC. | 0 | $0 | 0.00% | −6,785,177−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −511,107−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −405,043−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −308,877−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −280,077−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −218,241−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −104,511−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −94,054−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −76,061−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −72,248−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −61,458−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −48,330−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −39,036−100.0% | Sold out |
| Integrity Alliance, LLC. | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −33,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −31,060−100.0% | Sold out |
| Kapitalo Investimentos Ltda | 0 | $0 | 0.00% | −27,130−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −23,500−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Fifth Third Wealth Advisors LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,149−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −18,028−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −16,126−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −15,700−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −14,477−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −13,522−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −11,404−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −11,400−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −10,498−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −1,253−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −339−100.0% | Sold out |
| St Germain D J Co Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |